Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, et al. Patient nonadherence to medication in inflammatory bowel disease. The American journal of gastroenterology. 2003;98(7):1535-44.
Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. The American journal of medicine. 2003;114(1):39-43.
Hawthorne A, Rubin G, Ghosh S. medication non‐adherence in ulcerative colitis–strategies to improve adherence with mesalazine and other maintenance therapies. Alimentary pharmacology & therapeutics. 2008;27(12):1157-66.
Higgins PD, Rubin D, Kaulback K, Schoenfield P, Kane S. Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Alimentary pharmacology & therapeutics. 2009;29(3):247-57.
Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. The American journal of gastroenterology. 2001;96(10):2929-33.
Kane SV, Sumner M, Solomon D, Jenkins M. Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database. Digestive diseases and sciences. 2011;56(12):3463-70.
Ingerski LM, Baldassano RN, Denson LA, Hommel KA. Barriers to oral medication adherence for adolescents with inflammatory bowel disease. Journal of pediatric psychology. 2009;35(6):683-91.
Kane S. Systematic review: adherence issues in the treatment of ulcerative colitis. Alimentary pharmacology & therapeutics. 2006;23(5):577-85.
Kane SV, Hanauer SB. Medication adherence is associated with improved outcomes in patients with quiescent ulcerative colitis (UC). Gastroenterology. 2000;118(4):A886.
Trindade AJ, Ehrlich A, Kornbluth A, Ullman TA. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflammatory bowel diseases. 2011;17(2):599-604.
Bermejo F, Román AL-S, Algaba A, Guerra I, Valer P, García-Garzón S, et al. Factors that modify therapy adherence in patients with inflammatory bowel disease☆. Journal of Crohn's and Colitis. 2010;4(4):422-6.
Greenley RN, Kunz JH, Biank V, Martinez A, Miranda A, Noe J, et al. Identifying youth nonadherence in clinical settings: data-based recommendations for children and adolescents with inflammatory bowel disease. Inflammatory bowel diseases. 2011;18(7):1254-9.
Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nature clinical practice Gastroenterology & hepatology. 2006;3(7):390-407.
Tiao DK, Chan W, Jeganathan J, Chan JT, Perry J, Selinger CP, et al. Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis. Inflammatory bowel diseases. 2017;23(8):1257-61.
Bhatt J, Patil S, Joshi A, Abraham P, Desai D. Self-reported treatment adherence in inflammatory bowel disease in Indian patients. Indian Journal of Gastroenterology. 2009;28(4):143-6.
Chan W, Chen A, Tiao D, Selinger C, Leong R. Medication adherence in inflammatory bowel disease. Intestinal research. 2017;15(4):434-45.
Robinson A. Improving adherence to medication in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics. 2008;27(s1):9-14.
San Roman AL, Bermejo F, Carrera E, Pérez-Abad M, Boixeda D. Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig. 2005;97(4):249-57.
Lennard-Jones J. Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 1989;24(sup170):2-6.
Krousel-Wood M, Islam T, Webber LS, Re R, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in hypertensive seniors. The American journal of managed care. 2009;15(1):59.
Kane SV, Robinson A. understanding adherence to medication in ulcerative colitis–innovative thinking and evolving concepts. Alimentary pharmacology & therapeutics. 2010;32(9):1051-8.
Sewitch MJ, Abrahamowicz M, Bitton A, Daly D, Wild GE, Cohen A, et al. Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. The American journal of gastroenterology. 2001;96(5):1470-9.
Shale M, Riley S. Studies of compliance with delayed‐release mesalazine therapy in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics. 2003;18(2):191-8.
Červený P, Bortlík M, Kuběna A, Vlček J, Lakatos PL, Lukáš M. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflammatory bowel diseases. 2007;13(10):1244-9.
Kim SB, Kim KO, Jang BI, Kim ES, Cho KB, Park KS, et al. Patients' beliefs and attitudes about their treatment for inflammatory bowel disease in Korea. Journal of gastroenterology and hepatology. 2016;31(3):575-80.
San Román AL, Bermejo F, Carrera E, Pérez-Abad M, Boixeda D. Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig. 2005;97(4):249-57.
Bucci C, Zingone F, Tammaro S, Iovino P, Santonicola A, Ciacci C. Factors predicting the adherence to the therapy of Italian IBD patients. Gastroenterology research and practice. 2017;2017.
Ghadir MR, Bagheri M, Vahedi H, Daryani NE, Malekzadeh R, Hormati A, et al. Nonadherence to Medication in Inflammatory Bowel Disease: Rate and Reasons. Middle East journal of digestive diseases. 2016;8(2):116.
Burgess SW, Sly PD, Morawska A, Devadason SG. Assessing adherence and factors associated with adherence in young children with asthma. Respirology. 2008;13(4):559-63.
Marhefka SL, Koenig LJ, Allison S, Bachanas P, Bulterys M, Bettica L, et al. Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications. AIDS Patient Care and STDs. 2008;22(8):637-47.
Zelikovsky N, Schast AP. Eliciting accurate reports of adherence in a clinical interview: development of the Medical Adherence Measure. Pediatric Nursing. 2008;34(2).